Hippocratic AI vs Tempus AI (2026): Pricing, Features & Which to Choose

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

Lower starting price
Not comparable
Not comparable: Hippocratic AI does not list a price
Free plan
Tie
Neither has one
Higher rating
Tie
4.3 against 4.3
Same job?
Yes
Both are Healthcare AI tools

Side by side

Compared on	Hippocratic AI	Tempus AI
Our rating	4.3	4.3
Starts at	Not listed	Not listed
Free plan	No	No
Category	Healthcare AI	Healthcare AI
Plans	See pricing	See pricing
Key features	Patient-facing AI agents for pre-visit intake, follow-up, and check-ins Deliberately restricted from prescribing or diagnosing by design 115 million-plus clinical patient interactions with no reported safety issues Partnerships with 50+ health systems, payers, and pharmaceutical companies $126M Series C at a $3.5B valuation in November 2025	Machine learning applied to genomic and clinical data for precision treatment matching One of the largest connected libraries of clinical and molecular data Publicly traded on Nasdaq under the ticker TEM Q1 2026 revenue of $348.1M, up 36.1% year over year 2026 revenue guidance raised to $1.59-$1.60 billion
Pros	Non-diagnostic scope reduces liability risk compared to diagnostic AI agents Massive interaction volume with a clean safety record builds real trust Strong recent funding at a high valuation supports continued expansion	Publicly reported financials give unusual transparency into scale and growth Massive, growing data library strengthens precision-matching over time Strong, consistent revenue growth across both diagnostics and data segments
Cons	Enterprise pricing requires a sales conversation, no published self-serve rate Deliberately limited scope means it won't replace diagnostic or prescribing tools Young company, founded 2023, with a shorter track record than established competitors	Pricing runs through insurance billing and enterprise agreements, not published rates Built specifically for precision medicine and oncology, a narrower clinical scope Best suited to institutions already positioned to act on genomic testing results
Company	Hippocratic AI, founded 2023	Tempus AI, founded 2015

Prices come from each vendor's pricing page, last checked 20260714. Check the vendor before you buy.

FAQ

Questions people ask

Is Hippocratic AI better than Tempus AI?

In our reviews Hippocratic AI scores 4.3 and Tempus AI scores 4.3. The better pick depends on the job. Hippocratic AI: 115 million patient interactions with zero safety incidents, and it still won't diagnose. Tempus AI: Publicly traded on Nasdaq, guiding to $1.6 billion in 2026 revenue.

Which is cheaper, Hippocratic AI or Tempus AI?

Hippocratic AI: see pricing. Tempus AI: see pricing.

Do Hippocratic AI and Tempus AI have free plans?

Neither lists a free plan.

More comparisons

Hippocratic AI compared with

All Hippocratic AI alternatives

Tempus AI compared with

All Tempus AI alternatives